When
October 14, 2015
12:00 - 1:30 p.m.
Where
Cambridge Innovation Center
One Broadway, 5th Floor Havana Room
Cambridge, MA 02142
More Info
10 Intellectual Property Considerations for Protecting Your Company’s Innovations
In partnership with the MIT Enterprise Forum of Cambridge, we invite you come for lunch and learn how businesses are reaping rewards by protecting their core technologies/products through strategic procurement and use of intellectual property (IP) rights.
You have worked hard to get your company on its feet. You protect it daily against a host of challenges. Are you protecting some of the most valuable assets of your company – your innovations? Protecting your innovations through intellectual property strategies, including patenting, freedom-to-operate studies, trademarks, employment agreements, confidentiality agreements and consulting agreements, are critical to the long-term success of your start-up.
Attendees will learn 10 considerations for strategically protecting and using intellectual property.
Other highlights include –
- Identifying your company’s valuable intellectual property
- Avoiding pitfalls that can forfeit your patent rights
- Determining if patenting your innovation is the right step for your business
- Determining the best timing to protect your innovation
- Creating a value proposition for potential investors
We will introduce you to the tools you need to identify and protect your intellectual property rights.
Mary Lou Wakimura and Eric Balicky, Ph.D., have over 40 years of combined experience in strategic patent and trademark counseling in the electrical arts and life sciences, respectively. They are dedicated to guiding clients through the development, management, and protection of intellectual property rights to achieve business goals.
 | Mary Lou, a Principal, has helped many startups in the greater Boston area develop and grow their businesses using various IP strategies. Her approach includes playing to the strengths of patents, trademarks and copyrights for the different aspects of a client’s innovation. Mary Lou played a key role in the patenting of technology for startups in the social media and e-commerce industries, as well as for companies in other software and computer-related industries. Mary Lou has served as outside IP Counsel for companies through the phases of the business lifecycle from initial startup and rounds of funding to acquisition or merger. Mary Lou enjoys retaining long-term relationships with clients and offering cohesion to the IP portfolio over time and changes in client management.
|
 | Eric, a Senior Associate, has over 11 years of experience drafting and prosecuting patents in the biotechnology, pharmaceutical, chemistry and medical device areas. Eric’s clients include companies ranging from small start-ups to large pharmaceutical corporations, as well as universities, venture capital groups and individuals. Eric also has experience in patent litigation, trademark prosecution, licensing transactions and IP due diligence, including the preparation of freedom-to-operate, patentability, non-infringement and invalidity opinions. |
Guest Speakers:
 | Steven Kates, Ph.D. is Vice President of Research at Ischemix, LLC. He is a highly experienced chemist with over 25 years experience in Research and Development for both life science products and human therapeutics. During his industrial career, he has advanced several compounds through drug development from early pre-clinical to clinical development and commercialization. He has managed and led project teams including pre-clinical (non-clinical pharmacology and toxicology), chemistry, manufacturing and controls (CMC), regulatory, clinical and medical affairs. He possess a broad scientific and development expertise in various therapeutic areas and, through the years, has been involved in strategic corporate development and communications, discovery research, product development, project management and strategic alliances. Steve has managed patent portfolios and expanded intellectual property by filing provisional and continuances to existing patents. He has identified, qualified and managed multi-functional CRO activities, including ex-US vendors for research and manufacturing of lead compounds leading to IND and NDA filings. He is the author of over 100 publications, reviews and patents, including two books and maintains a faculty position at Northeastern University.
|
 | Drew Zalkind has over 25 years experience working day-and-night, side-by-side with management teams and investors to maximize the value of their opportunities. He combines strategic analysis, extensive financing knowledge, and efficient execution to help successfully build, focus, and fund teams. His experience ranges from Fortune 500 firms to high-tech startups across a diverse range of industries. Most recently, he was CFO for Yottaa (a Web acceleration platform) and CEO & CFO of Liquid Machines (a data security company). In prior lives, Drew was an investment banker, venture investor, and strategy consultant. Over the years, he has served as an advisor to numerous firms and non-profits. Drew has a B.S. in Marketing from the Wharton School of Business and a B.A. in Psychology from University of Pennsylvania. |
When
October 14, 2015
12:00 - 1:30 p.m.
Where
Cambridge Innovation Center
One Broadway, 5th Floor Havana Room
Cambridge, MA 02142
In partnership with the MIT Enterprise Forum of Cambridge, we invite you come for lunch and learn how businesses are reaping rewards by protecting their core technologies/products through strategic procurement and use of intellectual property (IP) rights.
You have worked hard to get your company on its feet. You protect it daily against a host of challenges. Are you protecting some of the most valuable assets of your company – your innovations? Protecting your innovations through intellectual property strategies, including patenting, freedom-to-operate studies, trademarks, employment agreements, confidentiality agreements and consulting agreements, are critical to the long-term success of your start-up.
Attendees will learn 10 considerations for strategically protecting and using intellectual property.
Other highlights include –
- Identifying your company’s valuable intellectual property
- Avoiding pitfalls that can forfeit your patent rights
- Determining if patenting your innovation is the right step for your business
- Determining the best timing to protect your innovation
- Creating a value proposition for potential investors
We will introduce you to the tools you need to identify and protect your intellectual property rights.
Mary Lou Wakimura and Eric Balicky, Ph.D., have over 40 years of combined experience in strategic patent and trademark counseling in the electrical arts and life sciences, respectively. They are dedicated to guiding clients through the development, management, and protection of intellectual property rights to achieve business goals.
| Mary Lou, a Principal, has helped many startups in the greater Boston area develop and grow their businesses using various IP strategies. Her approach includes playing to the strengths of patents, trademarks and copyrights for the different aspects of a client’s innovation. Mary Lou played a key role in the patenting of technology for startups in the social media and e-commerce industries, as well as for companies in other software and computer-related industries. Mary Lou has served as outside IP Counsel for companies through the phases of the business lifecycle from initial startup and rounds of funding to acquisition or merger. Mary Lou enjoys retaining long-term relationships with clients and offering cohesion to the IP portfolio over time and changes in client management.
|
| Eric, a Senior Associate, has over 11 years of experience drafting and prosecuting patents in the biotechnology, pharmaceutical, chemistry and medical device areas. Eric’s clients include companies ranging from small start-ups to large pharmaceutical corporations, as well as universities, venture capital groups and individuals. Eric also has experience in patent litigation, trademark prosecution, licensing transactions and IP due diligence, including the preparation of freedom-to-operate, patentability, non-infringement and invalidity opinions. |
Guest Speakers:
| Steven Kates, Ph.D. is Vice President of Research at Ischemix, LLC. He is a highly experienced chemist with over 25 years experience in Research and Development for both life science products and human therapeutics. During his industrial career, he has advanced several compounds through drug development from early pre-clinical to clinical development and commercialization. He has managed and led project teams including pre-clinical (non-clinical pharmacology and toxicology), chemistry, manufacturing and controls (CMC), regulatory, clinical and medical affairs. He possess a broad scientific and development expertise in various therapeutic areas and, through the years, has been involved in strategic corporate development and communications, discovery research, product development, project management and strategic alliances. Steve has managed patent portfolios and expanded intellectual property by filing provisional and continuances to existing patents. He has identified, qualified and managed multi-functional CRO activities, including ex-US vendors for research and manufacturing of lead compounds leading to IND and NDA filings. He is the author of over 100 publications, reviews and patents, including two books and maintains a faculty position at Northeastern University.
|
| Drew Zalkind has over 25 years experience working day-and-night, side-by-side with management teams and investors to maximize the value of their opportunities. He combines strategic analysis, extensive financing knowledge, and efficient execution to help successfully build, focus, and fund teams. His experience ranges from Fortune 500 firms to high-tech startups across a diverse range of industries. Most recently, he was CFO for Yottaa (a Web acceleration platform) and CEO & CFO of Liquid Machines (a data security company). In prior lives, Drew was an investment banker, venture investor, and strategy consultant. Over the years, he has served as an advisor to numerous firms and non-profits. Drew has a B.S. in Marketing from the Wharton School of Business and a B.A. in Psychology from University of Pennsylvania. |